NEXGEL, Inc. (NXGLW) stock
NXGLWNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31Also trades as NXGL
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 17, 2026Score 6/3072% below fair value
$0.01+0.00 (0.00%)
Close on Oct 30, 2026Market cap $34.21MP/E –Yield –
Nexgel revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Nexgel's revenue for the twelve months ending Jun 30, 2026 was $12.07M, up 3.4% year over year. For fiscal 2025 it was $11.42M, up 31.5% from the year before. The highest annual figure on record is $11.42M in fiscal 2025.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $11.42M | +31.5% |
| FY2024 | Dec 31, 2024 | $8.69M | +112.5% |
| FY2023 | Dec 31, 2023 | $4.09M | +99.7% |
| FY2022 | Dec 31, 2022 | $2.05M | +32.0% |
| FY2021 | Dec 31, 2021 | $1.55M | +130.1% |
| FY2020 | Dec 31, 2020 | $674.00K | -6.0% |
| FY2019 | Dec 31, 2019 | $717.00K | -67.6% |
| FY2018 | Dec 31, 2018 | $2.21M | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $3.69M | +27.8% |
| Q1 FY2026 | Mar 31, 2026 | $2.65M | -5.6% |
| Q4 FY2025 | Dec 31, 2025 | $2.80M | -8.1% |
| Q3 FY2025 | Sep 30, 2025 | $2.93M | -0.2% |
| Q2 FY2025 | Jun 30, 2025 | $2.88M | +100.3% |
| Q1 FY2025 | Mar 31, 2025 | $2.81M | +121.6% |
| Q4 FY2024 | Dec 31, 2024 | $3.04M | +181.1% |
| Q3 FY2024 | Sep 30, 2024 | $2.94M | +140.8% |
| Q2 FY2024 | Jun 30, 2024 | $1.44M | +23.4% |
| Q1 FY2024 | Mar 31, 2024 | $1.27M | +104.2% |
| Q4 FY2023 | Dec 31, 2023 | $1.08M | +106.5% |
| Q3 FY2023 | Sep 30, 2023 | $1.22M | +115.0% |
| Q2 FY2023 | Jun 30, 2023 | $1.17M | +108.0% |
| Q1 FY2023 | Mar 31, 2023 | $620.00K | +56.6% |
| Q4 FY2022 | Dec 31, 2022 | $524.00K | -1.7% |
| Q3 FY2022 | Sep 30, 2022 | $568.00K | +69.6% |
| Q2 FY2022 | Jun 30, 2022 | $561.00K | +34.5% |
| Q1 FY2022 | Mar 31, 2022 | $396.00K | +48.3% |
| Q4 FY2021 | Dec 31, 2021 | $533.00K | +427.7% |
| Q3 FY2021 | Sep 30, 2021 | $335.00K | +38.4% |
| Q2 FY2021 | Jun 30, 2021 | $417.00K | +358.2% |
| Q1 FY2021 | Mar 31, 2021 | $267.00K | +11.3% |
| Q4 FY2020 | Dec 31, 2020 | $101.00K | -42.6% |
| Q3 FY2020 | Sep 30, 2020 | $242.00K | -15.7% |
| Q2 FY2020 | Jun 30, 2020 | $91.00K | -27.2% |
| Q1 FY2020 | Mar 31, 2020 | $240.00K | +86.0% |
| Q4 FY2019 | Dec 31, 2019 | $176.00K | -61.8% |
| Q3 FY2019 | Sep 30, 2019 | $287.00K | -17.5% |
| Q2 FY2019 | Jun 30, 2019 | $125.00K | -85.5% |
| Q1 FY2019 | Mar 31, 2019 | $129.00K | – |
| Q4 FY2018 | Dec 31, 2018 | $461.00K | – |
| Q3 FY2018 | Sep 30, 2018 | $348.00K | – |
| Q2 FY2018 | Jun 30, 2018 | $864.00K | – |